Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2022 / Articles / Feb / Gearing Up for the 2022 Power List and More
Business & Regulation Advanced Medicine Bioprocessing - Upstream & Downstream Small Molecules Business Practice Profession Trends & Forecasts Bioprocessing Biopharma Small Molecules Business & Trends

Gearing Up for the 2022 Power List and More

Award Season is rolling in. Don’t miss out on submitting nominations for the Power List and voting for the Company of the Year Awards

02/15/2022 1 min read Quick Read (pre 2022)

Share

2022 is well underway, and with the new year comes a new arrival: The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too, and now it’s more exclusive than ever. Entries are already open, and the clocks are ticking. Are you excited? We’re excited! Read on for more information, and links to the relevant voting pages.

The Company of the Year Awards 2022
 

We’re gearing up to celebrate the best companies in the pharmaceutical industry across six categories:

  • Best Big Pharma
  • Best Biopharma Equipment Company
  • Best CDMO
  • Best API Supplier
  • Best Processing Equipment Company
  • Biggest “Talking Point”

We’ve used various sources to select the top ten contenders in each category (but you can suggest alternatives) so now it’s over to you to vote for the companies you want to see crowned the winners. Ballots close on March 17 2022, so head on over to the voting page (tmm.txp.to/coya-intro).

The Medicine Maker Power List 2022
 

Of course, individual human beings matter too. As ever, we want to celebrate the most inspirational and influential medicine makers out there, and we want to hear who you think they are. Head over to the nominations page (tmm.txp.to/pl-2022) and drop a name into our judging pool. We’re looking for ten winners in each of our three categories:

  • Small Molecules
  • Biopharmaceuticals
  • Advanced Medicine

As with the Company of the Award, voting closes on March 17 2022. All winners will be announced in April.

Questions? Contact stephanie.sutton@texerepublishing.com

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

Don’t Forget CDx Developers
Advanced Medicine
Don’t Forget CDx Developers

November 7, 2014

0 min read

Many drug developers are going ‘full steam ahead’ with personalized medicine strategies. They would be wise to consider a more equitable business model for an essential partner in the process: the developer of the companion diagnostic.

The Next Decade of Cell and Gene Therapies
Advanced Medicine Bioprocessing - Upstream & Downstream Trends & Forecasts Digital Technologies
The Next Decade of Cell and Gene Therapies

May 7, 2025

5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.

Peter Marks Resigns from FDA
Standards & Regulation Profession Vaccines Advanced Medicine
Peter Marks Resigns from FDA

April 1, 2025

3 min read

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr. “Rather he wishes subservient confirmation of his misinformation and lies.”

The Trump Effect on Cell and Gene: Science versus Shockwaves
Business Practice Standards & Regulation Trends & Forecasts Advanced Medicine
The Trump Effect on Cell and Gene: Science versus Shockwaves

April 1, 2025

9 min read

Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.